Evidence map›Paper›PMID 36353706›Full record

ArticleJournal of oncology2022

Ultraviolet Radiation Promoted Hypoxia-Induced Apoptosis in HL-60 Human Promyelocytic Leukemia Cell Line.

Yilin Wang, Jiandong Sun, Dong Xie, Ren Zhong, Shaoyong Si, Xiaotong Liu, Zhenghai Qu, Lirong Sun, Lingzhen Wang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yilin WangDepartment of Pediatric Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Jiandong SunPediatric Intensive Care Department, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Dong XieDepartment of Pediatric Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Ren ZhongDepartment of Pediatric Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Shaoyong SiDepartment of Pediatric Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Xiaotong LiuDepartment of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Zhenghai QuDepartment of Pediatrics, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Lirong SunDepartment of Pediatric Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.ORCID https://orcid.org/0000-0002-9887-8289
Lingzhen WangDepartment of Pediatric Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.ORCID https://orcid.org/0000-0002-1937-9730
Qingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Minimal residual disease (MRD) is an important reason for the failure of autologous hematopoietic stem cell transplantation (auto-HSCT). Reducing MRD in grafts is particularly important to improve the efficacy of auto-HSCT. Previously, we reported that ultraviolet light-emitting diode (UV LED) suppressed the expression of Bcl-2 to induce apoptosis in HL-60 cells. Leukemia can lead to severe hypoxia of the bone marrow. Therefore, this study aimed to investigate the effect of UV LED on leukemia cells under hypoxia. HL-60 cells were irradiated with a UV LED (30 J/m

Identifiers

PMID36353706
PMCPMC9640238
OpenAlexW4307734617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.